Diabetic eye disease includes a group of eye-related problems that affect people with diabetes. Eye examinations provide effective clues for the detection of diseases such as diabetic eye disease. Diabetic eye disease can lead to permanent vision loss, including blindness and low vision. Diabetic eye disease can cause severe vision loss, which means people’s eyesight isn’t very good enough to easily perform everyday tasks.
Diabetic eye disease may affect the retina, lens, vitreous gel, and optic nerve. Major diabetic eye diseases include cataracts, glaucoma, diabetic retinopathy and diabetic macular edema. Diabetic retinopathy is the most common cause of vision loss in people with diabetes and the leading cause of blindness in working-age adults.
Get a sample copy of this report @ https://www.persistencemarketresearch.com/samples/23032
The effects of diabetic eye disease, such as vision loss and blindness, have created a need for early detection of diabetic eye disease. Diabetic eye exams and prompt treatment can prevent vision loss. According to the National Eye Institute (NEI), approximately 7.7 million people age 40 and older have diabetic retinopathy, and the total number of people with diabetes is projected to increase from 285 million in 2010 to 439 million in 2030. The increase in the number of diabetic patients globally will lead to an increasing demand for diabetic eye tests.
The global diabetic eye testing market is expected to witness favorable growth over the forecast period owing to increasing incidence of diabetic eye disease. According to the Centers for Disease Control and Prevention (CDC), 1.8 million of the 37 million cases of blindness worldwide are due to diabetic retinopathy.
The increasing adoption of unhealthy lifestyles and unhealthy diets has led to an increase in the number of people living with diabetes and obesity. The launch of telemedicine imaging technology products will drive the growth of the diabetic eye testing market. These telemedicine-based products can capture high-quality retinal scans and share those images digitally with eye care professionals.
The growing popularity of innovative retinal imaging scanners among clinicians as an effective test for diabetic eye disease will boost the growth of the diabetic eye test market. Initiatives by government associations to raise awareness about diabetic eye diseases such as blindness and diabetic retinopathy will drive the growth of the diabetic eye testing market.
The reduction of disease prevalence by the domestic government through programs such as diabetes eye screening programs will drive the growth of the diabetes eye testing market. Rising demand for innovative testing devices, technological advancements, and increasing R&D efforts to develop more affordable and efficient testing devices will drive the diabetic ophthalmic testing market over the forecast period.
Request Catalog @ https://www.persistencemarketresearch.com/toc/23032
The Global Diabetic Eye Testing Market is segmented on the basis of Product Type, Test Type and End User:
segmentation
| Product Category |
|
| test type |
|
| end user |
|
Visit the full report @ https://www.persistencemarketresearch.com/checkout/23032
Sales of visual acuity testing, tonometer, pupil dilation, fluorescein angiography and optical coherence tomography testing products are increasing the demand for diabetic eye testing. A tonometer measures the pressure inside the eye. Pupil dilation allows doctors to examine the retina and optic nerve.
Optical coherence tomography is a technique that uses light waves instead of sound waves to capture images of tissue in the body. OCT provides detailed images of eye tissue that can be penetrated by light.
Regionally, the global diabetes eye testing market is segmented into six key regions, viz. North America, Latin America, Europe, Asia Pacific (excluding China), China, and Middle East & Africa. North America is expected to lead the global market owing to high adoption of advanced products.
According to the Centers for Disease Control and Prevention, diabetes (types 1 and 2) affects more than 29 million people in the United States. The diabetes eye testing market in Europe also showed the second highest witnessed growth. However, the diabetes eye testing market in Asia Pacific is expected to witness significant growth over the forecast period.
Some of the players operating in the global diabetic eye testing market include Carl Zeiss AG, Haag-Streit Holding, Topcon Corporation, NIDEK Co., Ltd, Novarand, Heidelberg Engineering, Inc., Escalon Medical Corp., Novartis International AG, Valeant Pharmaceuticals International , Inc., Canon Inc., Essilor Group, HEINE Optotechnik GmbH & Co. KG and Luneau Technology Group, etc.
About us: Persistence Market Research
Contact us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – www.persistencemarketresearch.com